← FDA ENFORCEMENT
D-0553-2026Class I

Wisconsin Pharmacal Company

Recalling firm
Wisconsin Pharmacal Company
Product type
Drug
Status
Ongoing
Report date
2026-05-27
Distribution
USA Nationwide and Bahamas
Firm state
WI
Product quantity
690 tubes
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Environmental Monitoring
Reason for recall

Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.

Product description

MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.

Code / lot info

Lot #: 1024088, Exp 11/30/2026

Other recalls SPEQ maps to Environmental Monitoring
2026-07-22Class IFrutas y Hortalizas del Sur S.A.2026-07-22Class IIGELLERT GLOBAL GROUP2026-07-22Class IIChiesi USA, Inc.2026-07-22Class IICareFusion 213, LLC
See all Environmental Monitoring recalls →

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.